CA Stock MarketDetailed Quotes

EDT Spectral Medical Inc

Watchlist
  • 0.580
  • -0.060-9.38%
15min DelayMarket Closed Sep 27 16:00 ET
163.12MMarket Cap-8285P/E (TTM)

Spectral Medical Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.48%-2.4M
64.98%-1.22M
-8.29%-10.72M
26.66%-1.66M
-56.48%-3.48M
29.67%-2.09M
-43.00%-3.5M
-13.78%-9.9M
-13.52%-2.26M
6.24%-2.22M
Net income from continuing operations
-3.85%-4.4M
-265.55%-4.16M
-38.84%-15.66M
-161.89%-6.56M
-18.98%-3.73M
-43.45%-4.24M
57.66%-1.14M
-28.41%-11.28M
1.92%-2.5M
-51.67%-3.14M
Operating gains losses
-741.98%-841K
291.24%1.31M
248.67%1.74M
238.27%1.57M
2,873.08%721K
1,107.69%131K
-11,516.67%-685K
-4,222.22%-1.17M
-3,810.34%-1.13M
58.73%-26K
Depreciation and amortization
16.07%65K
5.08%62K
-19.85%218K
-16.92%54K
-22.22%49K
-21.13%56K
-19.18%59K
-7.48%272K
-8.45%65K
-11.27%63K
Asset impairment expenditure
----
----
--600K
----
----
----
----
----
----
--8K
Remuneration paid in stock
9.32%1.08M
780.77%177K
24.31%1.49M
-2.08%188K
56.22%339K
938.95%987K
-103.75%-26K
-4.92%1.2M
35.21%192K
97.27%217K
Other non cashItems
320.80%1.15M
123.90%609K
161.20%1.31M
51.77%730K
400.00%30K
4,466.67%274K
3,785.71%272K
1,685.71%500K
6,771.43%481K
-14.29%6K
Change In working capital
-21.20%550K
139.35%778K
-170.12%-406K
140.30%1.76M
-237.36%-886K
365.40%698K
-269.53%-1.98M
132.95%579K
182.63%732K
250.70%645K
-Change in receivables
-7.14%130K
-270.11%-296K
202.23%870K
154.49%534K
-8.33%22K
-24.73%140K
314.81%174K
-1,647.27%-851K
-370.72%-980K
108.70%24K
-Change in inventory
-22.95%47K
622.22%47K
44.68%-26K
-119.38%-62K
91.88%-16K
8.93%61K
96.02%-9K
7.84%-47K
--320K
-91.26%-197K
-Change in prepaid assets
116.61%48K
37.78%-359K
-157.60%-345K
-44.25%291K
-32.94%230K
-7,125.00%-289K
-120.23%-577K
223.25%599K
728.92%522K
681.36%343K
-Change in payables and accrued expense
-54.92%417K
66.96%-453K
-117.06%-267K
-8.02%986K
-233.39%-807K
455.77%925K
-1,026.35%-1.37M
352.83%1.57M
473.26%1.07M
326.06%605K
-Change in other current assets
----
----
--0
----
----
----
----
---26K
----
----
-Change in other working capital
33.81%-92K
1,047.94%1.84M
3.48%-638K
105.68%10K
-142.31%-315K
42.32%-139K
-70.18%-194K
-0.76%-661K
14.98%-176K
1.52%-130K
Cash from discontinued investing activities
Operating cash flow
-14.48%-2.4M
64.98%-1.22M
-8.29%-10.72M
26.66%-1.66M
-56.48%-3.48M
29.67%-2.09M
-43.00%-3.5M
-13.78%-9.9M
-13.52%-2.26M
6.24%-2.22M
Investing cash flow
Cash flow from continuing investing activities
-14.29%-8K
-16K
-460.61%-185K
-424.56%-185K
110.14%7K
63.16%-7K
0
89.85%-33K
5,800.00%57K
-102.94%-69K
Net PPE purchase and sale
-14.29%-8K
---16K
-460.61%-185K
-424.56%-185K
110.14%7K
63.16%-7K
--0
89.85%-33K
5,800.00%57K
-102.94%-69K
Cash from discontinued investing activities
Investing cash flow
-14.29%-8K
---16K
-460.61%-185K
-424.56%-185K
110.14%7K
63.16%-7K
--0
89.85%-33K
5,800.00%57K
-102.94%-69K
Financing cash flow
Cash flow from continuing financing activities
3,068.30%7.87M
1,196.97%362K
-42.43%5.44M
-102.52%-238K
59,900.00%5.98M
-1,004.17%-265K
-197.06%-33K
-22.26%9.46M
32,710.34%9.46M
-100.11%-10K
Net issuance payments of debt
28,396.67%8.49M
0.00%-33K
5.93%3.93M
-162.96%-2.39M
21,386.67%6.39M
-3.45%-30K
-13.79%-33K
3,384.07%3.71M
13,200.00%3.8M
-7.14%-30K
Net common stock issuance
----
----
--0
----
----
----
----
-59.75%4.03M
----
----
Proceeds from stock option exercised by employees
--617K
--395K
--0
--0
--0
--0
--0
-97.42%88K
--0
-61.54%20K
Net other financing activities
----
----
-7.35%1.51M
--2.15M
----
----
----
244.51%1.63M
----
----
Cash from discontinued financing activities
Financing cash flow
3,068.30%7.87M
1,196.97%362K
-42.43%5.44M
-102.52%-238K
59,900.00%5.98M
-1,004.17%-265K
-197.06%-33K
-22.26%9.46M
32,710.34%9.46M
-100.11%-10K
Net cash flow
Beginning cash position
-57.55%2.07M
-64.92%2.95M
-5.35%8.41M
322.42%5.03M
-27.26%2.52M
-24.51%4.89M
-5.35%8.41M
53.09%8.89M
-89.10%1.19M
-20.69%3.47M
Current changes in cash
330.95%5.46M
75.11%-878K
-1,047.48%-5.46M
-128.65%-2.08M
209.08%2.51M
21.66%-2.37M
-46.27%-3.53M
-115.16%-476K
459.39%7.26M
-135.45%-2.3M
Effect of exchange rate changes
----
----
----
----
----
----
----
----
----
-58.73%26K
End cash Position
198.93%7.54M
-57.55%2.07M
-64.92%2.95M
-64.92%2.95M
322.42%5.03M
-27.26%2.52M
-24.51%4.89M
-5.35%8.41M
-5.35%8.41M
-89.10%1.19M
Free cash from
-14.48%-2.4M
64.52%-1.24M
-9.80%-10.91M
16.36%-1.84M
-51.46%-3.47M
29.88%-2.1M
-42.89%-3.5M
-8.16%-9.93M
-6.28%-2.2M
4.70%-2.29M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.48%-2.4M64.98%-1.22M-8.29%-10.72M26.66%-1.66M-56.48%-3.48M29.67%-2.09M-43.00%-3.5M-13.78%-9.9M-13.52%-2.26M6.24%-2.22M
Net income from continuing operations -3.85%-4.4M-265.55%-4.16M-38.84%-15.66M-161.89%-6.56M-18.98%-3.73M-43.45%-4.24M57.66%-1.14M-28.41%-11.28M1.92%-2.5M-51.67%-3.14M
Operating gains losses -741.98%-841K291.24%1.31M248.67%1.74M238.27%1.57M2,873.08%721K1,107.69%131K-11,516.67%-685K-4,222.22%-1.17M-3,810.34%-1.13M58.73%-26K
Depreciation and amortization 16.07%65K5.08%62K-19.85%218K-16.92%54K-22.22%49K-21.13%56K-19.18%59K-7.48%272K-8.45%65K-11.27%63K
Asset impairment expenditure ----------600K--------------------------8K
Remuneration paid in stock 9.32%1.08M780.77%177K24.31%1.49M-2.08%188K56.22%339K938.95%987K-103.75%-26K-4.92%1.2M35.21%192K97.27%217K
Other non cashItems 320.80%1.15M123.90%609K161.20%1.31M51.77%730K400.00%30K4,466.67%274K3,785.71%272K1,685.71%500K6,771.43%481K-14.29%6K
Change In working capital -21.20%550K139.35%778K-170.12%-406K140.30%1.76M-237.36%-886K365.40%698K-269.53%-1.98M132.95%579K182.63%732K250.70%645K
-Change in receivables -7.14%130K-270.11%-296K202.23%870K154.49%534K-8.33%22K-24.73%140K314.81%174K-1,647.27%-851K-370.72%-980K108.70%24K
-Change in inventory -22.95%47K622.22%47K44.68%-26K-119.38%-62K91.88%-16K8.93%61K96.02%-9K7.84%-47K--320K-91.26%-197K
-Change in prepaid assets 116.61%48K37.78%-359K-157.60%-345K-44.25%291K-32.94%230K-7,125.00%-289K-120.23%-577K223.25%599K728.92%522K681.36%343K
-Change in payables and accrued expense -54.92%417K66.96%-453K-117.06%-267K-8.02%986K-233.39%-807K455.77%925K-1,026.35%-1.37M352.83%1.57M473.26%1.07M326.06%605K
-Change in other current assets ----------0-------------------26K--------
-Change in other working capital 33.81%-92K1,047.94%1.84M3.48%-638K105.68%10K-142.31%-315K42.32%-139K-70.18%-194K-0.76%-661K14.98%-176K1.52%-130K
Cash from discontinued investing activities
Operating cash flow -14.48%-2.4M64.98%-1.22M-8.29%-10.72M26.66%-1.66M-56.48%-3.48M29.67%-2.09M-43.00%-3.5M-13.78%-9.9M-13.52%-2.26M6.24%-2.22M
Investing cash flow
Cash flow from continuing investing activities -14.29%-8K-16K-460.61%-185K-424.56%-185K110.14%7K63.16%-7K089.85%-33K5,800.00%57K-102.94%-69K
Net PPE purchase and sale -14.29%-8K---16K-460.61%-185K-424.56%-185K110.14%7K63.16%-7K--089.85%-33K5,800.00%57K-102.94%-69K
Cash from discontinued investing activities
Investing cash flow -14.29%-8K---16K-460.61%-185K-424.56%-185K110.14%7K63.16%-7K--089.85%-33K5,800.00%57K-102.94%-69K
Financing cash flow
Cash flow from continuing financing activities 3,068.30%7.87M1,196.97%362K-42.43%5.44M-102.52%-238K59,900.00%5.98M-1,004.17%-265K-197.06%-33K-22.26%9.46M32,710.34%9.46M-100.11%-10K
Net issuance payments of debt 28,396.67%8.49M0.00%-33K5.93%3.93M-162.96%-2.39M21,386.67%6.39M-3.45%-30K-13.79%-33K3,384.07%3.71M13,200.00%3.8M-7.14%-30K
Net common stock issuance ----------0-----------------59.75%4.03M--------
Proceeds from stock option exercised by employees --617K--395K--0--0--0--0--0-97.42%88K--0-61.54%20K
Net other financing activities ---------7.35%1.51M--2.15M------------244.51%1.63M--------
Cash from discontinued financing activities
Financing cash flow 3,068.30%7.87M1,196.97%362K-42.43%5.44M-102.52%-238K59,900.00%5.98M-1,004.17%-265K-197.06%-33K-22.26%9.46M32,710.34%9.46M-100.11%-10K
Net cash flow
Beginning cash position -57.55%2.07M-64.92%2.95M-5.35%8.41M322.42%5.03M-27.26%2.52M-24.51%4.89M-5.35%8.41M53.09%8.89M-89.10%1.19M-20.69%3.47M
Current changes in cash 330.95%5.46M75.11%-878K-1,047.48%-5.46M-128.65%-2.08M209.08%2.51M21.66%-2.37M-46.27%-3.53M-115.16%-476K459.39%7.26M-135.45%-2.3M
Effect of exchange rate changes -------------------------------------58.73%26K
End cash Position 198.93%7.54M-57.55%2.07M-64.92%2.95M-64.92%2.95M322.42%5.03M-27.26%2.52M-24.51%4.89M-5.35%8.41M-5.35%8.41M-89.10%1.19M
Free cash from -14.48%-2.4M64.52%-1.24M-9.80%-10.91M16.36%-1.84M-51.46%-3.47M29.88%-2.1M-42.89%-3.5M-8.16%-9.93M-6.28%-2.2M4.70%-2.29M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data